Center for Autoimmune Diseases, Sheba Medical Center affiliated with the Tel-Aviv University, Tel-Hashomer 52621, Israel.
BMC Med. 2013 Aug 22;11:185. doi: 10.1186/1741-7015-11-185.
Over the last few years, accumulating data have implicated a role for ferritin as a signaling molecule and direct mediator of the immune system. Hyperferritinemia is associated with a multitude of clinical conditions and with worse prognosis in critically ill patients.
There are four uncommon medical conditions characterized by high levels of ferritin, namely the macrophage activation syndrome (MAS), adult onset Still's disease (AOSD), catastrophic antiphospholipid syndrome (cAPS) and septic shock, that share a similar clinical and laboratory features, and also respond to similar treatments, suggesting a common pathogenic mechanism. Ferritin is known to be a pro-inflammatory mediator inducing expression of pro-inflammatory molecules, yet it has opposing actions as a pro-inflammatory and as an immunosuppressant. We propose that the exceptionally high ferritin levels observed in these uncommon clinical conditions are not just the product of the inflammation but rather may contribute to the development of a cytokine storm.
Here we review and compare four clinical conditions and the role of ferritin as an immunomodulator. We would like to propose including these four conditions under a common syndrome entity termed "Hyperferritinemic Syndrome".
在过去的几年中,越来越多的数据表明铁蛋白作为一种信号分子和免疫系统的直接介质发挥作用。高铁蛋白血症与多种临床情况相关,并与危重病患者的预后较差相关。
有四种罕见的医学病症以高水平的铁蛋白为特征,即巨噬细胞活化综合征(MAS)、成人Still 病(AOSD)、灾难性抗磷脂综合征(cAPS)和感染性休克,这些病症具有相似的临床和实验室特征,并且对相似的治疗有反应,提示存在共同的发病机制。铁蛋白是一种促炎介质,可诱导促炎分子的表达,但它具有促炎和免疫抑制的相反作用。我们提出,在这些罕见的临床病症中观察到的异常高的铁蛋白水平不仅仅是炎症的产物,而是可能导致细胞因子风暴的发生。
在这里,我们回顾和比较了四种临床病症以及铁蛋白作为免疫调节剂的作用。我们建议将这四种病症归入一个共同的综合征实体,称为“高铁蛋白血症综合征”。